Latest news

Debiopharm International SA and Solid Biosciences, LLC, announce a collaboration to explore the use of Alisporivir (Debio 025) in muscular…

Debiopharm International SA acquires FibroTrap sample processing technology from Spinomix

Debiopharm International SA Announces Phase III Positive Results for Triptorelin 6-month Formulation in the Management of Central Precocious Puberty (CPP)

Debiopharm International SA initiates clinical phase II study evaluating Debio 1450 in Staphylococcal skin infections

Debiopharm International SA announces results of 2 key oncology programs at 2015 AACR Conference

Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital

Debiopharm Group regains full rights to Alisporivir program

FDA Grants Fast Track designation to Debiopharm Group’s antibiotic Debio 1450

Debiopharm Investment, Ardian, Nixdorf Foundation and Bernis today acquire Eco Delta solar activities